NASDAQ
Akoya Biosciences, Inc. (AKYA) has a free cash flow growth of -84.34% as of Friday, May 29, 2026. This represents a 155.90% decrease compared to its 12-month average of -32.96%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.